Evidence map›Paper›PMID 38550635›Full record

ArticleCurrent research in toxicology2024

Investigation of

Fatima den Ouden, Andrea Estévez-Danta, Lidia Belova, Celine Gys, Anna Klimowska, Maarten Roggeman, Natan Van Wichelen, José Benito Quintana, Rosario Rodil, Giulia Poma and 1 more

Open access · goldAbstract read
In one paragraph

Article in Current research in toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Fatima den OudenToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Andrea Estévez-DantaDepartment of Analytical Chemistry, Nutrition and Food Chemistry. Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Lidia BelovaToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Celine GysToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Anna KlimowskaToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Maarten RoggemanToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Natan Van WichelenToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
José Benito QuintanaDepartment of Analytical Chemistry, Nutrition and Food Chemistry. Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Rosario RodilDepartment of Analytical Chemistry, Nutrition and Food Chemistry. Institute of Research on Chemical and Biological Analysis (IAQBUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Giulia PomaToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
Adrian CovaciToxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
University of Antwerp · BEUniversidade de Santiago de Compostela · ESGdańsk Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tris (1-chloro-2-propyl) phosphate (TCIPP) is one of the major organophosphate flame retardants present in the indoor and outdoor environment. Knowledge of biotransformation pathways is important to elucidate potential bioavailability and toxicity of TCIPP and to identify relevant biomarkers. This study aimed to identify TCIPP metabolites through

Indexed as

Human exposomeHuman liver cytosolHuman liver microsomesIn vitro metabolismIn vivo metabolismTCIPP

Identifiers

PMID38550635
PMCPMC10973591
OpenAlexW4393002554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.